Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy  Based on the Findings in Turkey, a Country with a High Rate of  Consanguineous Marriages

parman, yesim; Candayan, Ayse; Battaloglu, Esra

doi:10.4274/balkanmedj.galenos.2021.2021-11-13

Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages

Ayse Candayan, (Boğaziçi Üniversitesi, Moleküler Biyoloji ve Genetik Bölümü, İstanbul, Türkiye)

Yeşim PARMAN, (İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Nöroloji Anabilim Dalı, İstanbul, Türkiye)

Esra Battaloglu (Boğaziçi Üniversitesi, Moleküler Biyoloji ve Genetik Bölümü, İstanbul, Türkiye)

Balkan Medical Journal

3 0

Yıl: 2022 Cilt: 39 Sayı: 1 Sayfa Aralığı: 3 - 11 Metin Dili: İngilizce DOI: 10.4274/balkanmedj.galenos.2021.2021-11-13 İndeks Tarihi: 10-10-2022

Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages

Öz:

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Pisciotta C, Shy ME. Neuropathy. Handb Clin Neurol. 2018;148:653-665. [CrossRef]
2. De Jonghe P, Timmerman V, Nelis E, Martin JJ, Van Broeckhoven C. Charcot-Marie Tooth disease and related peripheral neuropathies. J Peripher Nerv Syst. 1997;2:370- 387. [CrossRef]
3. Laurá M, Pipis M, Rossor AM, Reilly MM. Charcot-marie-Tooth disease and related disorders: An evolving landscape. Curr Opin Neurol. 2019;32:641-650. [CrossRef]
4. Timmerman V, Strickland AV, Züchner S. Genetics of Charcot-Marie-Tooth (CMT) disease within the frame of the human genome project success. Genes (Basel). 2014;5:13-32. [CrossRef]
5. Parman Y, Battaloǧlu E. Recessively transmitted predominantly motor neuropathies. Handb Clin Neurol. 2013;115:847-861. [CrossRef]
6. Rossor AM, Evans MRB, Reilly MM. A practical approach to the genetic neuropathies. Pract Neurol. 2015;15:187-198. [CrossRef]
7. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth’s disease. Clin Genet. 1974;6:98-118. [CrossRef]
8. Barreto LC, Oliveira FS, Nunes PS, et al. Epidemiologic Study of Charcot-Marie Tooth Disease: A Systematic Review. Neuroepidemiology. 2016;46:157-165. [CrossRef]
9. Bird TD, Ott J, Giblett ER. Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am J Hum Genet. 1982;34:388- 394. [CrossRef]
10. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991;66:219-232. [CrossRef]
11. Parman Y, Battaloǧlu E, Baris I, Bilir B, et al. Clinicopathological and genetic study of early-onset demyelinating neuropathy. Brain. 2004;127:2540-2550. [CrossRef]
12. Pareyson D, Scaioli, Laurà M. Clinical and Electrophysiological Aspects of Charcot Marie-Tooth Disease. Neuromolecular Med. 2006;8:3-22. [CrossRef]
13. Davis CJ, Bradley WG, Madrid R. The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. J Genet Hum. 1978;26:311-349. [CrossRef]
14. Nave KA, Sereda MW, Ehrenreich H. Mechanisms of disease: Inherited demyelinating neuropathies - From basic to clinical research. Nat Clin Pract Neurol. 2007;3:453- 464. [CrossRef]
15. Siskind CE, Panchal S, Smith CO, et al. A review of genetic counseling for Charcot Marie Tooth disease (CMT). J Genet Couns. 2013;22:422-436. [CrossRef]
16. Brennan KM, Bai Y, Shy ME. Demyelinating CMT -- what’s known, what’s new and what’s in store? Neurosci Lett. 2015;2:14-26. [CrossRef]
17. Tazir M, Bellatache M, Nouioua S, Vallat JM. Autosomal recessive Charcot-Marie Tooth disease: From genes to phenotypes. J Peripher Nerv Syst. 2013;18:113-129. [CrossRef]
18. Mathis S, Goizet C, Tazir M, et al. Charcot-Marie-Tooth diseases: an update and some new proposals for the classification. J Med Genet. 2015;52:681-690. [CrossRef]
19. Chance PF, Alderson MK, Leppig KA, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 1993;72:143-151. [CrossRef]
20. Murphy SM, Laura M, Fawcett K, et al. Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry. 2012;83:706-710. [CrossRef]
21. Kleopa KA. The role of gap junctions in Charcot-Marie-Tooth disease. J Neurosci. 2011;31:17753-17760. [CrossRef]
22. Tazir M, Hamadouche T, Nouioua S, Mathis S, Vallat JM. Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: An update. J Neurol Sci. 2014;347:14-22. [CrossRef]
23. Züchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet. 2004;36:449- 451. [CrossRef]
24. Nicholson GA, Magdelaine C, Zhu D, et al. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations. Neurology. 2008;70:1678-1681. [CrossRef]
25. Bis-Brewer DM, Fazal S, Züchner S. Genetic modifiers and non-Mendelian aspects of CMT. Brain Res. 2020;1726:146459. [CrossRef]
26. Zimoń M, Battaloğlu E, Parman Y, et al. Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach. Neurogenetics. 2015;16:33-42. [CrossRef]
27. Zimoń M, Baets J, Almeida-Souza L, et al. Loss-of-function mutations in HINT1 cause axonal neuropathy with neuromyotonia. Nat Genet. 2012;44:1080-1083. [CrossRef]
28. Peeters K, Chamova T, Tournev I, Jordanova A. Axonal neuropathy with neuromyotonia: There is a HINT. Brain. 2017;140:868-877. [CrossRef]
29. Snipes GJ, Suter U, Welcher AA, Shooter EM. Characterization of a novel peripheral nervous system myelin protein (PMP- 22/SR13). J Cell Biol. 1992;117:225-238. [CrossRef]
30. Greenfield S, Brostoff S, Eylar EH, Morell P. Protein Composition of Myelin of the Peripheral Nervous System. J Neurochem. 1973;20:1207-1216. [CrossRef]
31. D’Urso D, Ehrhardt P, Müller HW. Peripheral myelin protein 22 and protein zero: A novel association in peripheral nervous system myelin. J Neurosci. 1999;19:3396- 3403. [CrossRef]
32. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet. 1995;11:274-280. [CrossRef]
33. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet. 1995;11:281-286. [CrossRef]
34. Fortun J, Go JC, Li J, Amici SA, Dunn WA Jr, Notterpek L. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression. Neurobiol Dis. 2006;22:153-164. [CrossRef]
35. Mäurer M, Kobsar I, Berghoff M, Schmid CD, Carenini S, Martini R. Role of immune cells in animal models for inherited neuropathies: facts and visions. J Anat. 2002;200:405-414. [CrossRef]
36. Wang Ip C, Kroner A, Fischer S, et al. Role of immune cells in animal models for inherited peripheral neuropathies. Neuromolecular Med. 2006;8:175-190. [CrossRef]
37. Pareyson D, Saveri P, Sagnelli A, Piscosquito G. Mitochondrial dynamics and inherited peripheral nerve diseases. Neurosci Lett. 2015;596:66-77. [CrossRef]
38. Espinós C, Galindo MI, García-Gimeno MA, et al. Oxidative Stress, a Crossroad Between Rare Diseases and Neurodegeneration. Antioxidants (Basel). 2020;9:313. [CrossRef]
39. Mersiyanova IV, Perepelov AV, Polyakov AV, et al. A new variant of Charcot-Marie Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet. 2000;67:37-46. [CrossRef]
40. Rebelo AP, Abrams AJ, Cottenie E, et al. Cryptic Amyloidogenic Elements in the 3’ UTRs of Neurofilament Genes Trigger Axonal Neuropathy. Am J Hum Genet. 2016;98:597-614. [CrossRef]
41. Verhoeven K, De Jonghe P, Coen K, et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet. 2003;72:722-727. [CrossRef]
42. Züchner S, Noureddine M, Kennerson M, et al. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet. 2005;37:289-294. [CrossRef]
43. Hinshaw JE. Dynamin and its role in membrane fission. Annu Rev Cell Dev Biol. 2000;16:483-519. [CrossRef]
44. Schafer DA, Weed SA, Binns D, Karginov AV, Parsons JT, Cooper JA. Dynamin2 and cortactin regulate actin assembly and filament organization. Curr Biol. 2002;12:1852- 1857. [CrossRef]
45. Weedon MN, Hastings R, Caswell R, et al. Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease e. Am J Hum Genet. 2011;89:308-312. [CrossRef]
46. Puls I, Jonnauty C, LaMonte BH, et al. Mutant dynactin in motor neuron disease. Nat Genet. 2003;33:455-456. [CrossRef]
47. De Vos KJ, Grierson AJ, Ackerley S, Miller CC. Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci. 2008;31:151-173. [CrossRef]
48. Evgrafov OV, Mersiyanova I, Irobi J, et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet. 2004;36:602-606. [CrossRef]
49. Irobi J, Van Impe K, Seeman P, et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathyy. Nat Genet. 2004;36:597-601. [CrossRef]
50. Kolb SJ, Snyder PJ, Poi EJ, et al. Mutant small heat shock protein B3 causes motor neuropathy: utility of a candidate gene approach h. Neurology. 2010;74:502-506. [CrossRef]
51. Pitceathly RD, Murphy SM, Cottenie E, et al. Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. Neurology. 2012;79:1145-1154. [CrossRef]
52. Fay A, Garcia Y, Margeta M, et al. A Mitochondrial tRNA Mutation Causes Axonal CMT in a Large Venezuelan Family. Ann Neurol. 2020;88:830-842. [CrossRef]
53. Rudnik-Schöneborn S, Tölle D, Senderek J, et al. Diagnostic algorithms in Charcot Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients. Clin Genet. 2016;89:34-43. [CrossRef]
54. Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME. Charcot-Marie Tooth disease subtypes and genetic testing strategies. Ann Neurol. 2011;69:22-33. [CrossRef]
55. DiVincenzo C, Elzinga CD, Medeiros AC, et al. The allelic spectrum of Charcot Marie-Tooth disease in. Mol Genet Genomic Med. 2014;2:522-529. [CrossRef]
56. Miller LJ, Saporta ASD, Sottile SL, Siskind CE, Feely SME, Shy ME. Strategy for genetic testing in Charcot-Marie-Disease. Acta Myol. 2011;30:109-116. [CrossRef]
57. Østern R, Fagerheim T, Hjellnes H, Nygård B, Mellgren SI, Nilssen Ø. Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies. BMC Med Genet. 2013;14:94. [CrossRef]
58. Azzedine H, Ravisé N, Verny C, et al. Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations. Neurology. 2006;67:602-606. [CrossRef]
59. Sevilla T, Jaijo T, Nauffal D, et al. Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy. Brain. 2008;131:3051-3061. [CrossRef]
60. Slatko BE, Gardner AF, Ausubel FM. Overview of Next-Generation Sequencing Technologies. Curr Protoc Mol Biol. 2018;122:59. [CrossRef]
61. Lupo V, García-García F, Sancho P, et al. Assessment of Targeted Next-Generation Sequencing as a Tool for the Diagnosis of Charcot-Marie-Tooth Disease and Hereditary Motor Neuropathy. J Mol Diagn. 2016;18:225-234. [CrossRef]
62. Cortese A, Wilcox JE, Polke JM, et al. Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease. Neurology. 2020;94:51-61. [CrossRef]
63. Pipis M, Rossor AM, Laura M, Reilly MM. Next-generation sequencing in Charcot Marie-Tooth disease: opportunities and challenges. Nat Rev Neurol. 2019;15:644- 656. [CrossRef]
64. Nam SH, Hong YB, Hyun YS, et al. Identification of Genetic Causes of Inherited Peripheral Neuropathies by Targeted Gene Panel Sequencing. Mol Cells. 2016;39:382- 388. [CrossRef]
65. Wang W, Wang C, Dawson DB, et al. Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy. Neurology. 2016;86:1762-1771. [CrossRef]
66. Candayan A, Çakar A, Yunisova G, et al. Genetic Survey of Autosomal Recessive Peripheral Neuropathy Cases Unravels High Genetic Heterogeneity in a Turkish Cohort. Neurol Genet. 2021;7:621. [CrossRef]
67. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: Past successes for mendelian disease, future approaches for complex disease. Nat Genet. 2003;33(suppl):228-237. [CrossRef]
68. Choi BO, Koo SK, Park MH, et al. Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth Disease. Hum Mutat. 2012;33:1610-1615. [CrossRef]
69. Mantere T, Kersten S, Hoischen A. Long-read sequencing emerging in medical genetics. Front Genet. 2019;10:426. [CrossRef]
70. Xiao T, Zhou W. The third generation sequencing: The advanced approach to genetic diseases. Transl Pediatr. 2020;9:163-173. [CrossRef]
71. Yoshimura A, Yuan JH, Hashiguchi A, et al. Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan. J Neurol Neurosurg Psychiatry. 2019;90:195-202. [CrossRef]
72. Pareyson D, Marchesi C. Diagnosis, natural history, and management of Charcot Marie-Tooth disease. Lancet Neurol. 2009;8:654-667. [CrossRef]
73. Fridman V, Bundy B, Reilly MM, et al. CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross sectional analysis. J Neurol Neurosurg Psychiatry. 2015;86:873-878. [CrossRef]
74. Candayan A, Yunisova G, Çakar A, et al. The first biallelic missense mutation in the FXN gene in a consanguineous Turkish family with Charcot-Marie-Tooth-like phenotype. Neurogenetics. 2020;21:73-78. [CrossRef]
75. Tey S, Shahrizaila N, Drew AP, et al. Linkage analysis and whole exome sequencing reveals AHNAK2 as a novel genetic cause for autosomal recessive CMT in a Malaysian family. Neurogenetics. 2019;20:117-127. [CrossRef]
76. Ylikallio E, Woldegebriel R, Tumiati M, et al. MCM3AP in recessive Charcot Marie-Tooth neuropathy and mild intellectual disability. Brain. 2017;140:2093-2103. [CrossRef]
77. Stendel C, Roos A, Deconinck T, et al. Peripheral nerve demyelination caused by a mutant Rho GTPase guanine nucleotide exchange factor, frabin/FGD4. Am J Hum Genet. 2007;81:158-164. [CrossRef]
78. Senderek J, Bergmann C, Stendel C, et al. Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy. Am J Hum Genet. 2003;73:1106-1119. [CrossRef]
79. Sereda MW, Meyer zu Hörste G, Suter U, Uzma N, Nave KA. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med. 2003;9:1533-1537. [CrossRef]
80. Passage E, Norreel JC, Noack-Fraissignes P, et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med. 2004;10:396- 401. [CrossRef]
81. Burns J, Ouvrier RA, Yiu EM, et al. Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol. 2009;8:537-544. [CrossRef]
82. Morena J, Gupta A, Hoyle JC. Charcot-marie-tooth: From molecules to therapy. Int J Mol Sci. 2019;20:3419. [CrossRef]
83. Zhao HT, Damle S, Ikeda-Lee K, et al. PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models. J Clin Invest. 2018;128:359-368. [CrossRef]
84. Attarian S, Vallat JM, Magy L, et al. Erratum to: An exploratory randomised double blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. Orphanet J Rare Dis. 2016;11:92. [CrossRef]
85. Sahenk Z, Nagaraja HN, McCracken BS, et al. NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology. 2005;65:681-689. [CrossRef]
86. Sahenk Z, Ozes B. Gene therapy to promote regeneration in Charcot-Marie-Tooth disease. Brain Res. 2020;1727:146533. [CrossRef]
87. Bolino A, Piguet F, Alberizzi V, et al. Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination. EMBO Mol Med. 2016;8:1438-1454. [CrossRef]
88. Khajavi M, Shiga K, Wiszniewski W, et al. Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy. Am J Hum Genet. 2007;81:438-453. [CrossRef]
89. Rocha AG, Franco A, Krezel AM, et al. MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A. Science. 2018;360:336-341. [CrossRef]
90. Kagiava A, Karaiskos C, Richter J, et al. Intrathecal gene therapy in mouse models expressing CMT1X mutations. Hum Mol Genet. 2018;27:1460-1473. [CrossRef]

APA	Candayan A, parman y, Battaloglu E (2022). Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages. , 3 - 11. 10.4274/balkanmedj.galenos.2021.2021-11-13
Chicago	Candayan Ayse,parman yesim,Battaloglu Esra Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages. (2022): 3 - 11. 10.4274/balkanmedj.galenos.2021.2021-11-13
MLA	Candayan Ayse,parman yesim,Battaloglu Esra Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages. , 2022, ss.3 - 11. 10.4274/balkanmedj.galenos.2021.2021-11-13
AMA	Candayan A,parman y,Battaloglu E Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages. . 2022; 3 - 11. 10.4274/balkanmedj.galenos.2021.2021-11-13
Vancouver	Candayan A,parman y,Battaloglu E Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages. . 2022; 3 - 11. 10.4274/balkanmedj.galenos.2021.2021-11-13
IEEE	Candayan A,parman y,Battaloglu E "Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages." , ss.3 - 11, 2022. 10.4274/balkanmedj.galenos.2021.2021-11-13
ISNAD	Candayan, Ayse vd. "Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages". (2022), 3-11. https://doi.org/10.4274/balkanmedj.galenos.2021.2021-11-13

APA	Candayan A, parman y, Battaloglu E (2022). Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages. Balkan Medical Journal, 39(1), 3 - 11. 10.4274/balkanmedj.galenos.2021.2021-11-13
Chicago	Candayan Ayse,parman yesim,Battaloglu Esra Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages. Balkan Medical Journal 39, no.1 (2022): 3 - 11. 10.4274/balkanmedj.galenos.2021.2021-11-13
MLA	Candayan Ayse,parman yesim,Battaloglu Esra Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages. Balkan Medical Journal, vol.39, no.1, 2022, ss.3 - 11. 10.4274/balkanmedj.galenos.2021.2021-11-13
AMA	Candayan A,parman y,Battaloglu E Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages. Balkan Medical Journal. 2022; 39(1): 3 - 11. 10.4274/balkanmedj.galenos.2021.2021-11-13
Vancouver	Candayan A,parman y,Battaloglu E Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages. Balkan Medical Journal. 2022; 39(1): 3 - 11. 10.4274/balkanmedj.galenos.2021.2021-11-13
IEEE	Candayan A,parman y,Battaloglu E "Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages." Balkan Medical Journal, 39, ss.3 - 11, 2022. 10.4274/balkanmedj.galenos.2021.2021-11-13
ISNAD	Candayan, Ayse vd. "Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages". Balkan Medical Journal 39/1 (2022), 3-11. https://doi.org/10.4274/balkanmedj.galenos.2021.2021-11-13